Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A comprehensive report of disease complications of juvenile idiopathic arthritis using a prospective cohort study.
Journal: Pediatric rheumatology online journal
Published: October 22, 2025
Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic Arthritis.
Journal: The Journal of rheumatology
Published: September 22, 2025
Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network.
Journal: Frontiers in pediatrics
Published: May 17, 2024
Screening for juvenile idiopathic arthritis associated uveitis with laser flare photometry in the pediatric rheumatology office: a prospective observational study.
Journal: Pediatric rheumatology online journal
Published: December 21, 2023
Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis.
Journal: Arthritis care & research
Published: December 20, 2022
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.
Journal: Annals of the rheumatic diseases
Published: February 04, 2020
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 20, 2017
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 19, 2017
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 05, 2017
Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.
Journal: Pediatric rheumatology online journal
Published: May 14, 2014
Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.
Journal: Arthritis care & research
Published: February 12, 2014
Last Updated: 09/26/2026